Providers push back on 340B rebate model

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.

The retailer, which at one point had 14 MedWise sites, is divesting its nine-location network to Saint Francis Health System.

Hayley Park will oversee BSCA’s prescription drug programs. The insurer has worked to overhaul its pharmacy management model in a bid to lower drug costs.

Premium hikes, plan redesigns and other efforts from the Minnesota-based company to wrangle medical spending bore fruit in the first quarter. UnitedHealth’s stock jumped accordingly.

The influential physician association surveyed thousands of doctors and found that burnout last year was lower than in 2024 or 2023. Still, certain specialties, especially those on the front lines of care, face an elevated risk of burning out.
The insurer accused the radiology group of gaming the No Surprises Act to reap higher reimbursement. A judge tossed the case last week, saying Aetna needed to raise its complaints during the dispute resolution process.

Republicans largely praised the HHS secretary’s track record during a marathon of House hearings last week, but some GOP lawmakers raised concerns about proposed budget cuts to the National Institutes of Health.
The partnership adds access to a workflow for second reads of complex cases and other software features made by RadNet subsidiary DeepHealth.
Microsoft Dragon Copilot reduces documentation burdens and gives healthcare professionals more time to focus on patient care.
As medical AI scales, how are payers ensuring safe and compliant care?